Once breast cancer is transferred, it enters a more complex and difficult phase, and the severity of the transfer varies from one part to another, of which brain transfer is usually considered one of the most serious.
The major brain transfer lies first and foremost in the particular structure and functions of the brain. The brain is the nerve centre of the human body and controls key functions of consciousness, mind, movement, feeling, etc. When breast cancer cells are transferred to the brain, even small tumour stoves can result in a series of severe nervous system symptoms as a result of oppression or intrusion of the surrounding brain tissue, neurofibre. Patients may suddenly experience severe headaches, vomiting, blurred vision, weak or numb body, balance disorder, epilepsy and even coma. These symptoms not only cause great physical suffering to patients, but also seriously affect their ability to take care of themselves in their daily lives, rapidly disabling them from living independently and drastically reducing their quality of life.
The treatment of brain transfer is extremely challenging in terms of the difficulty of treatment. Due to the existence of a blood and brain barrier, many chemotherapy drugs used to treat breast cancer are difficult to reach effectively the brain tumor, thus limiting the effectiveness of chemotherapy. While it can be used for local treatment of brain tumours, the tolerance of the brain to radiation is relatively low and can lead to serious complications such as brain oedema and radioactive brain failure during exposure, further exacerbating the neurological damage of patients. Furthermore, the risk of surgical removal of brain tumours is extremely high because of the complex structure of the brain and the concentration of its functional areas, and a slight inactivity in the operation may lead to serious neurological deficiencies, such as loss of speech, paraplegia, etc. Even if the tumour is successfully removed and the post-operative relapse rate is higher, the patient is still at risk of re-emergence and deterioration.
The prognosis of breast cancer brain transfer patients is also relatively poor. People with brain transfer tend to have a shorter life than other parts. Even with active and integrated treatment, including surgery, treatment, chemotherapy and emerging target and immunotherapy, the median life of most patients remains limited, usually for a few months to about one or two years. This is due to the relatively rapid growth of brain transfer tumors and their susceptibility to fatal complications, such as the formation of encephalus, which, when it occurs, can quickly cause the patient ‘ s respiratory heart to stop and mortality to be extremely high.
By contrast, while bone transfer of breast cancer is common and can cause bone pains, fractures and so forth, there is a relatively wide variety of treatments, such as bone improvement drugs, which can effectively relieve bone pains and prevent fractures, as well as better pain suppression and control of local bone transfer stoves, and to some extent the survival and quality of life of patients. The pulmonary and liver transfers of breast cancer are equally severe and affect the functioning of the corresponding organs, but in the case of treatment, with the development of targeted and immunotherapy, some of the patients are able to benefit from certain survival benefits, and the control of symptoms is sometimes easier to achieve than brain transfer.
Breast cancer brain transfer is one of the most serious cases of breast cancer transfer because of its severe impact on the quality of life of patients, the difficulty of treatment and poor planning. However, this does not mean that the transfer of other parts can be ignored, which in any case requires the patient, his family and the medical team to work closely together to explore the best possible treatment to maximize the duration of life, improve the quality of life and give the patient psychological support and care.
Breast cancer
